How should I mix 5‑fluorouracil (5‑FU) 50 mg/mL with triamcinolone acetonide (TA) 40 mg/mL to achieve a 9 : 1 volume ratio of 5‑FU to TA?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Mix 5-FU 50 mg/mL with Triamcinolone Acetonide (TA) 40 mg/mL in a 9:1 Ratio

To achieve a 9:1 volume ratio of 5-FU to TA, draw 0.9 mL of 5-fluorouracil (50 mg/mL) and 0.1 mL of triamcinolone acetonide (40 mg/mL) into the same syringe for a total volume of 1.0 mL.

Practical Mixing Instructions

Basic Calculation

  • For 1 mL total volume: 0.9 mL 5-FU + 0.1 mL TA
  • For 2 mL total volume: 1.8 mL 5-FU + 0.2 mL TA
  • For 5 mL total volume: 4.5 mL 5-FU + 0.5 mL TA

The 9:1 ratio means that for every 10 parts of total mixture, 9 parts are 5-FU and 1 part is TA.

Final Concentrations in the Mixture

  • 5-FU concentration: 45 mg/mL (50 mg/mL × 0.9)
  • TA concentration: 4 mg/mL (40 mg/mL × 0.1)

Clinical Context

This 9:1 ratio is not the standard mixture used in dermatologic practice for keloids and hypertrophic scars. The evidence base predominantly supports different ratios:

Evidence-Based Ratios for Keloid/Scar Treatment

Most commonly studied and recommended ratios:

  • 1:1 ratio (equal volumes): 0.5 mL of each drug 1, 2, 3
  • 3:1 ratio (3 parts 5-FU to 1 part TA): Used in validated studies 1
  • 9:1 ratio (0.9 mL 5-FU + 0.1 mL TA): Less commonly reported but follows the same mixing principle

The combination of 5-FU and TA demonstrates superior efficacy compared to either agent alone, with odds ratios of 3.45 versus TA monotherapy and 4.17 versus 5-FU monotherapy 4. The combination also reduces telangiectasia risk compared to TA alone (OR 0.24) 4.

Important Caveats

  • Verify the intended ratio with the prescribing physician, as 9:1 is unusual for standard keloid treatment
  • Use aseptic technique when mixing
  • Mix gently to avoid creating air bubbles
  • Use immediately after mixing for optimal stability
  • The mixture should be administered intralesionally using appropriate needle gauge (typically 25-27 gauge)

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.